HDL Cholesterol Kits Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

The HDL Cholesterol Kits Market is segmented by Product Type (HDL and LDL/VLDL assay kit, HDL Cholesterol Direct Reagent Kit) End-User and by Geography.

HDL Cholesterol Kits Market Snapshot

HDL Cholesterol Kits Market
Study Period: 2018 - 2026
Base Year: 2021
Fastest Growing Market: Asia Pacific
Largest Market: North America
CAGR: 6.2 %
HDL Cholesterol Kits Market Size

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The HDL Cholesterol Kits market studied was projected to grow with a CAGR of 6.2% over the forecast period. The major factor attributing to the growth of the market is the increase in the prevalence of obesity and hyperlipidemia. According to the World Health Organization, in 2018, 40 million children under the age of 5 years were overweight or obese. According to OECD, Obesity levels are expected to be particularly high in the United States, Mexico, and England, where 47%, 39% and 35% of the population respectively are projected to be obese in 2030. Furthermore, the growing importance of cholesterol screening diabetics patients and increasing awareness programs on high cholesterol is boosting the market growth. However, errors and inaccuracy in HDL Cholesterol testing kits constraints the market.

Scope of the Report

As per the scope of the report HDL Cholesterol Kits are fluorometric assay that can measure the amounts of HDL cholesterol present in plasma or serum samples within a 96-well microtiter plate format. This report is segmented by Product Type, End-User, and Geography.

By Product Type
HDL and LDL/VLDL assay kit
HDL Cholesterol Direct Reagent Kit
By End-User
Hospitals
Diagnostic Laboratories
Others
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle-East and Africa
GCC
South Africa
Rest of Middle-East and Africa
South America
Brazil
Argentina
Rest of South America

Report scope can be customized per your requirements. Click here.

Key Market Trends

HDL and LDL/VLDL Assay Kit Segment is Dominating the HDL Cholesterol Kits Market.

HDL and LDL/VLDL Assay Kit is a quantitative colorimetric determination of HDL and LDL/VLDL cholesterol. Lipoproteins are strong predictors for coronary heart disease. Functional HDL offers protection by removing cholesterol from cells and atheroma. Higher concentrations of LDL and lower concentrations of functional HDL are strongly associated with cardiovascular disease due to a higher risk of atherosclerosis. The balances between high and low-density lipoproteins are solely genetically determined but can be changed by medications, food choices and other factors. The dominant share of the segment over the other is due to the varied range of function, by using these kits one can measure all the three type of lipoproteins, unlike the HDL cholesterol direct reagent kit. Furthermore, the increasing prevalence of obesity and hyperlipidemia is propelling the segment growth.

HDL Cholesterol Kits Market Growth

North America Dominates the Market and Expected to do Same in the Forecast Period

North America is expected to dominate the overall market, throughout the forecast period. The market growth is due to the factors such as the presence of key players, high prevalence of obesity and hyperlipidemia in the region, established healthcare infrastructure are some of the key factors accountable for its large share in the market. In this region the United States has the maximum share due to supportive healthcare policies, a high number of patients, and a developed healthcare market. According to the CDC, the prevalence of obesity was 42.4% in 2017-2018. As per the statistics, the increasing patient pool and increasing disposable revenue in this country boost the market growth of the region.

HDL Cholesterol Kits market growth

Competitive Landscape

The HDL Cholesterol Kits market is moderately competitive and consists of several major players. The major players of HDL cholesterol kits are focusing on the expansion of their presence in key markets such as the Asia Pacific, the Middle East, and Europe through distribution agreements and the opening of new manufacturing facilities. Some of the companies which are currently dominating the market are Abbott, Randox Laboratories Ltd., Thermo Fisher Scientific, Abcam plc, Merck KGaA, PerkinElmer, Inc, Diazyme Laboratories, Inc, Cell Biolabs, Inc., Oscar Medicare Pvt. Ltd.

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Increasing Incidence of Obesity and Hyperlipidaemia

      2. 4.2.2 Growing Importance of Cholesterol Screening among Diabetic Patients

      3. 4.2.3 Growing Awareness Programs for Risk High Cholesterol

    3. 4.3 Market Restraints

      1. 4.3.1 Errors and Inaccuracy in HDL Cholesterol Testing Methods

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Product Type

      1. 5.1.1 HDL and LDL/VLDL assay kit

      2. 5.1.2 HDL Cholesterol Direct Reagent Kit

    2. 5.2 By End-User

      1. 5.2.1 Hospitals

      2. 5.2.2 Diagnostic Laboratories

      3. 5.2.3 Others

    3. 5.3 Geography

      1. 5.3.1 North America

        1. 5.3.1.1 United States

        2. 5.3.1.2 Canada

        3. 5.3.1.3 Mexico

      2. 5.3.2 Europe

        1. 5.3.2.1 Germany

        2. 5.3.2.2 United Kingdom

        3. 5.3.2.3 France

        4. 5.3.2.4 Italy

        5. 5.3.2.5 Spain

        6. 5.3.2.6 Rest of Europe

      3. 5.3.3 Asia-Pacific

        1. 5.3.3.1 China

        2. 5.3.3.2 Japan

        3. 5.3.3.3 India

        4. 5.3.3.4 Australia

        5. 5.3.3.5 South Korea

        6. 5.3.3.6 Rest of Asia-Pacific

      4. 5.3.4 Middle-East and Africa

        1. 5.3.4.1 GCC

        2. 5.3.4.2 South Africa

        3. 5.3.4.3 Rest of Middle-East and Africa

      5. 5.3.5 South America

        1. 5.3.5.1 Brazil

        2. 5.3.5.2 Argentina

        3. 5.3.5.3 Rest of South America

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Abbott Laboratories

      2. 6.1.2 Randox Laboratories Ltd.

      3. 6.1.3 Thermo Fisher Scientific

      4. 6.1.4 Abcam plc

      5. 6.1.5 Merck KGaA

      6. 6.1.6 PerkinElmer, Inc

      7. 6.1.7 Diazyme Laboratories, Inc

      8. 6.1.8 Cell Biolabs, Inc.

      9. 6.1.9 Oscar Medicare Pvt. Ltd

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The HDL Cholesterol Kits Market market is studied from 2018 - 2026.

The HDL Cholesterol Kits Market is growing at a CAGR of 6.2% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2021.

Abbott , Randox Laboratories Ltd., Thermo Fisher Scientific, Abcam plc, Merck KGaA are the major companies operating in HDL Cholesterol Kits Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!